| Literature DB >> 15626342 |
Yongwu Hu1, Jie Wen, Lin Tang, Haijun Zhang, Xiaowei Zhang, Yan Li, Jing Wang, Yujun Han, Guoqing Li, Jianping Shi, Xiangjun Tian, Feng Jiang, Xiaoqian Zhao, Jun Wang, Siqi Liu, Changqing Zeng, Jian Wang, Huanming Yang.
Abstract
We studied structural and immunological properties of the SARS-CoV M (membrane) protein, based on comparative analyses of sequence features, phylogenetic investigation, and experimental results. The M protein is predicted to contain a triple-spanning transmembrane (TM) region, a single N-glycosylation site near its N-terminus that is in the exterior of the virion, and a long C-terminal region in the interior. The M protein harbors a higher substitution rate (0.6% correlated to its size) among viral open reading frames (ORFs) from published data. The four substitutions detected in the M protein, which cause non-synonymous changes, can be classified into three types. One of them results in changes of pI (isoelectric point) and charge, affecting antigenicity. The second changes hydrophobicity of the TM region, and the third one relates to hydrophilicity of the interior structure. Phylogenetic tree building based on the variations of the M protein appears to support the non-human origin of SARS-CoV. To investigate its immunogenicity, we synthesized eight oligopeptides covering 69.2% of the entire ORF and screened them by using ELISA (enzyme-linked immunosorbent assay) with sera from SARS patients. The results confirmed our predictions on antigenic sites.Entities:
Mesh:
Substances:
Year: 2003 PMID: 15626342 PMCID: PMC5172243 DOI: 10.1016/s1672-0229(03)01016-7
Source DB: PubMed Journal: Genomics Proteomics Bioinformatics ISSN: 1672-0229 Impact factor: 7.691
Fig. 1The distribution of GC content (I), charge (II), the predicted hydrophobicity and antigenicity (III) and secondary structures (IV) of the M protein.
The Biochemical Features of the M Protien
| Feature | No. of a.a. | Percent (%) | |
|---|---|---|---|
| Non-polar, neutral | Leu | 31 | 14.00 |
| Ala | 19 | 8.60 | |
| Ile | 18 | 8.10 | |
| Val | 16 | 7.20 | |
| Gly | 15 | 6.80 | |
| Phe | 11 | 5.00 | |
| Trp | 7 | 3.20 | |
| Met | 7 | 3.20 | |
| Pro | 5 | 2.30 | |
| Neutral polar | Thr | 13 | 5.90 |
| Asn | 13 | 5.90 | |
| Ser | 12 | 5.40 | |
| Tyr | 9 | 4.10 | |
| Gln | 5 | 2.30 | |
| Cys | 3 | 1.40 | |
| Positive polar | Arg | 15 | 6.80 |
| Lys | 6 | 2.70 | |
| His | 3 | 1.40 | |
| Negative polar | Asp | 6 | 2.70 |
| Glu | 7 | 3.20 | |
| Total | 221 | 100 | |
| pI value | 9.3 | ||
| Hydrophobicity (%) | 40.70 | ||
| Hydrophilicity (%) | 36.20 | ||
| Charge (+)(%) | 10.90 | ||
| Charge (-)(%) | 5.90 | ||
Fig. 2The predicted transmembrane domains of the M protein.
Fig. 3Predicted signal peptides and cleavage sites of the M protein in six coronaviruses.
Fig. 4The predicted transmembrane domains in six coronaviruses.
Fig. 5The multiple alignments of amino acid sequences of the M protein in 12 coronaviruses.
Fig. 6A phylogenetic tree of the coronaviruses based on the M protein. A: ClustalW, output by Treeview. B: ClustalW, output by Phylodraw. AIBV: avian infectious bronchitis virus: BCoV: bovine coronavirus; CCoV: canine coronavirus; FCoV: feline coronavirus; FIPV: feline infectious peritonitis virus: HCoV-229E: human coronavirus 229E; HCoV-OC43: human coronavirus OC43; MHV: murine hepatitis virus; PEDV: porcine epidemic diarrhea virus; PHEV: porcine hemagglutinating encephalomyelitis virus; PRCoV(PRV): porcine respiratory coronavirus; PTGV: porcine transmissible gastroenteritis virus; RCoV: rat coronavirus; RSCoV: rat sialodacryoadenitis coronavirus; SARS-CoV: the human SARS-associated coronavirus; TCoV (TVC): turkey coronavirus.
Predicted Local Changes of Biochemical Features by Substitution
| Isolate | Location | Position a. a. (nt) | Substitution a. a. (nt) | pI value | Hydrophobicity (%) | Hydrophilicity (%) | Charge (+) (%) | Charge (-) (%) |
|---|---|---|---|---|---|---|---|---|
| SIN2500 | Exterior (1-18) | 11 (26,409) | Glu/Lys (G/A) | 4.20–4.80 | (33.3) | (55.6) | 5.6–11.1 | 22.2-16.7 |
| CUHK_Su10 | TM I (19-37) | 27 (26,458) | Phe/Cys (T/G) | (5.60) | 73.7-68.4 | (10.5) | 0 | 0 |
| HKU_39849 | TM II (50-72) | 68 (26,581) | Ala/Val (C/T) | (7.90) | 63.6-68.2 | (9.1) | (4.5) | 0 |
| URBANI | Interior (99-221) | 154 (26,838) | Ser/Pro (T/C) | (9.80) | (30.9) | 45.5-44.7 | (15.4) | (7.3) |
Fig. 7The immunoassay of oligopeptides in a 96-well plate. The sample distribution listed in Table 3.
The ELISA result of synthetic oligopeptides
| Sample name | GD01 | GZ04 | GZ10 | ZX10 | ZX03 | ZX26 | ZX20 | BJ01 | BJ02 | BJ03 | BJ04 | Negative control |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M-001 | 0.498 | 0.167 | 0.668 | 0.505 | 0.040 | 0.032 | 0.053 | 1.394 | 0.235 | 0.149 | 0.453 | 0.014 |
| M-017 | 0.041 | 0.023 | 0.024 | 0.104 | 0.022 | 0.019 | 0.013 | 0.092 | 0.047 | 0.062 | 0.077 | 0.019 |
| M-103 | 0.076 | 0.032 | 0.038 | 0.081 | 0.017 | 0.016 | 0.013 | 0.068 | 0.063 | 0.073 | 0.088 | 0.035 |
| M-119 | 0.288 | 0.148 | 0.037 | 0.027 | 0.075 | 0.047 | 0.049 | 0.083 | 0.030 | 0.097 | 0.088 | 0.013 |
| M-137 | 0.706 | 0.668 | 0.857 | 0.707 | 0.117 | 0.126 | 0.103 | 0.882 | 0.580 | 0.780 | 0.880 | 0.111 |
| M-162 | 0.139 | 0.076 | 0.049 | 0.146 | 0.018 | 0.028 | 0.019 | 0.241 | 0.180 | 0.153 | 0.241 | 0.050 |
| M-189 | 0.128 | 0.085 | 0.331 | 0.030 | 0.138 | 0.126 | 1.622 | 0.259 | 0.837 | 0.294 | 0.515 | 0.021 |
| M-206 | 0.129 | 0.102 | 0.168 | 0.171 | 0.151 | 0.743 | 0.055 | 0.764 | 0.670 | 0.335 | 0.579 | 0.020 |
Fig. 8The average immune reactivity of 8 oligopeptides by ELISA. Four oligopeptides show higher absorbance, suggesting immune reactivity with sera from SARS patients. Synthetic oligopeptides cover all the three predicted subregions of the M protein except for partial TM regions with extremely high hydrophobicity and low predicted antigenicity.
Fig. 9A diagram of the predicted TM structure in the SARS-CoV M protein.
Synthetic Oligopeptides of the M Protein in SARS-CoV
| Name | Amino acid residua | Position (a. a.) |
|---|---|---|
| M001 | KKMADNGTITVEELKQLLEQWN | 1–20 |
| M017 | KKEQWNLVIGFLFLAWIMLLQFAYSNR | 17–41 |
| M103 | KKARTRSMWSFNPETNILLNVPLR | 103–124 |
| M119 | KKLNVPLRGTIVTRPLMESELVIG | 119–140 |
| M137 | KKLVIGAVIIRGHLRM AGHSLGR | 137–157 |
| M162 | KKKDLPKEITVATSRTLSYYKLGASQR | 162–186 |
| M189 | KKDSGFAAYNRYRIGNYKLNTDHAG | 189–211 |
| M206 | KKNTDHAGSNDNIALLVQ | 206–221 |